ADMA Biologics, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, announced the Company has executed a definitive credit agreement with Ares Management credit...
Read Story
December 19, 2023, 07:49 AM
|
ADMA Biologics, Inc., a late-stage biopharmaceutical company developing specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that it has entered into a loan and security agreement with Oxford...
Read Story
June 22, 2015, 07:16 AM
|